Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials.
about
Evolution of hepatitis B management in kidney transplantationKidney Transplantation From Donors with Hepatitis BAntiviral treatment for chronic hepatitis B in renal transplant patientsPost-transplant infections: An ounce of prevention.Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategiesAdefovir nephrotoxicity in a renal allograft recipientPretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation: A Multicenter Cohort Study in Korea.Hepatitis B virus infection and renal transplantationChronic viral hepatitis in kidney transplantation.Management of HBV in immunocompromised patients.Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.Pharmacotherapeutic options for hepatitis B.Post-transplant withdrawal of lamivudine results in fatal hepatitis flares in kidney transplant recipients, under immune suppression, with inactive hepatitis B infection.Inferior graft survival of hepatitis B core positive grafts is not influenced by post-transplant hepatitis B infection in liver recipients--5-year single-center experience.Hepatitis B in renal transplant patients.Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation.Management of HBV infection during immunosuppressive treatmentEntecavir treatment in kidney transplant recipients infected with hepatitis B.Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy.Lamivudine therapy for hepatitis B infection in post-renal transplant patients: results after 36 months follow-up.Safety of using hepatitis B virus core antibody or surface antigen-positive donors in kidney or pancreas transplantation.Outcomes of kidney transplantation in patients with hepatitis B virus infection: A systematic review and meta-analysis.
P2860
Q26995706-B3BE48DA-75FF-4666-98D8-1EF45373A093Q28079212-F0B0AF79-A440-4835-B354-26ECE7232332Q28084189-9435B028-8BCC-418E-BF03-956D69A3DEE0Q34435191-95A96935-1AB3-40DA-87BB-8D9C7B6DE5ADQ35637506-6FF389BF-F985-4C77-B0EB-B429BA5FEDFAQ35658786-4717A195-67AA-4D3A-A494-6B55A594A136Q36992877-85F6821D-678D-4A2F-A9B0-9B1742CB75A4Q37780176-C2F614AF-4E49-4550-AE24-9E775973769DQ37833898-A3B10A6E-39E4-4507-8F90-2CCBF7D73031Q38071405-B0C3E6A9-FBCD-4A23-816B-B6932874E253Q38168296-BA0CCD9A-C56C-4F9C-A847-2B292FB4C6D4Q38631076-8754235F-F21C-41B0-9B18-65488BF4B214Q40211892-9E8B34B2-49F2-42BB-8FFB-2D7E0F52E5BCQ40851895-B4148097-6143-4BC7-ABA4-6EFE67B0ABF3Q41690591-18FFEE2D-6CB2-4E78-A590-83CACEFD56C8Q41779103-BCDE1C3C-4AC9-4DCA-843E-FEA39161DE4AQ41859437-DC1DDC7B-8B48-4C59-B9B9-25EEDEF81AEEQ42209408-58CC7338-0747-4F81-BEAB-AAFE9F391A80Q42231500-227477D3-883C-4105-83AA-42E023C5752FQ42248312-561354E2-6E54-4C12-9A6D-21156236C3D8Q43678974-457CDEEC-C26D-46E9-9CB9-94F0E0CB28D5Q43886978-C895DE16-E42F-4045-8EB2-E51F7FD77730Q45469494-D35D1456-F31F-4206-A96B-8D712B39EB2EQ53274315-3141D4CC-D967-4394-A4DA-2D0080BFBA19
P2860
Lamivudine for the treatment of hepatitis B virus-related liver disease after renal transplantation: meta-analysis of clinical trials.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Lamivudine for the treatment o ...... a-analysis of clinical trials.
@ast
Lamivudine for the treatment o ...... a-analysis of clinical trials.
@en
type
label
Lamivudine for the treatment o ...... a-analysis of clinical trials.
@ast
Lamivudine for the treatment o ...... a-analysis of clinical trials.
@en
prefLabel
Lamivudine for the treatment o ...... a-analysis of clinical trials.
@ast
Lamivudine for the treatment o ...... a-analysis of clinical trials.
@en
P2093
P1433
P1476
Lamivudine for the treatment o ...... a-analysis of clinical trials.
@en
P2093
Fabrizio Fabrizi
Gareth Dulai
Paul Martin
Suphamai Bunnapradist
Vivek Dixit
P304
P356
10.1097/01.TP.0000116448.97841.6D
P577
2004-03-01T00:00:00Z